Tag Archives: Warren Woessner

Director Kappos Comments on Ariad v. Lilly

Posted on May 6, 2010 by Warren Woessner

USPTO David Kappos recently posted a comment on the Fed. Cir. decision in Ariad v. Lilly in which he noted that the Fed. Cir. held that broad functional claims (presumably mechanism-of-action claims) must be supported by sufficient species (read “working examples”). While … Continue reading →

Posted in Written Description Requirements (WDR) | Tagged , , , , , | Leave a comment

Therasense To Be Re-Heard En Banc – “I Feel Your Pain”

Posted on April 28, 2010 by Warren Woessner

Monday’s decision by the Federal Circuit to vacate the split panel decision in Therasense, Inc. v. Becton Dickinson & Co., 593 F.3d 1289 (Fed. Cir. 2010) (link at end of post) and rehear the case en banc makes it impossible for … Continue reading →

Posted in Inequitable Conduct/Rule 56 | Tagged , , , , , , , | Leave a comment

Breaking News: Teeth Chatter In Hell – Vatican Funds To Support Stem Cell Research!

Posted on April 23, 2010 by Warren Woessner

The Vatican and the University of Maryland School of Medicine recently announced that the Vatican will contribute about $3M to fund research on stem cells derived from adult intestinal tissue. The funds will be used to support research at the … Continue reading →

Posted in Stem Cells/Cloning | Tagged , , , , , , , , | Leave a comment

Stem Cell Patents Webinar and BIO Int’l Convention Symposium

Posted on April 19, 2010 by Warren Woessner

Patent Claims Coverage Webinar: Stem Cell Industry – Osiris Therapeutics – Amgen’s EPO – Wed., April 28, 12:00PM – 12:50PM CDT Sunlight Research™ invites you to attend a Stem Cell Industry Patent Claims Coverage webinar presented by Robin A. Chadwick, … Continue reading →

Posted in Conferences and Classes, Stem Cells/Cloning | Tagged , , , , , , , | Leave a comment